Wang Jingpu, Yang Yang, Shafiulla Shaik Mohammed, Hu Jingfeng, Wang Kankan, Gao Chunzhi, Shan Tingting, Yin Dongfei
Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
Department of Thoracic Surgery, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
J Surg Res. 2020 Nov;255:195-204. doi: 10.1016/j.jss.2020.05.057. Epub 2020 Jun 18.
Most surgeons now accept lymphadenectomy as an essential feature of the operative treatment of esophageal squamous cell carcinoma. Three-field and two-field lymphadenectomy are two of the most popular excision scopes among surgeons. Over recent years, researchers have performed a range of comparative studies regarding these techniques, although the conclusions remain inconsistent.
We systematically retrieved the records of PubMed, Embase, The Cochrane Library, and ClinicalTrials.gov until October 2019 and performed preliminary and full-text screening of the articles. We used the NOS scale to evaluate the quality of the enrolled studies, with only medium- and high-quality studies included. Review Manager 5.3 and Stata15 were used for the meta-analysis.
A total of eight studies involving 1676 patients were included in the meta-analysis. The results showed that for esophageal squamous cell carcinoma using with two-field and three-field lymphadenectomy, although three-field lymphadenectomy led to the gaining of a higher number of lymph nodes, there were no significant differences between the two in terms of the number of positive lymph nodes and overall survival. Three-field lymphadenectomy also caused higher levels of intraoperative blood loss and higher morbidity of the anastomotic fistula. No significant differences in operation time, recurrent laryngeal nerve injury, pneumonia, chylothorax, anastomotic stenosis, ileus, cervical nodal recurrence and hospital mortality were observed.
According to our meta-analysis, two-field lymphadenectomy is recommended as a first-choice surgical treatment for esophageal squamous cell carcinoma. However, since the results showed a risk of bias, they should be treated with caution.
目前大多数外科医生认为淋巴结清扫术是食管鳞状细胞癌手术治疗的重要组成部分。三野和二野淋巴结清扫术是外科医生中最常用的两种切除范围。近年来,研究人员对这些技术进行了一系列比较研究,但其结论仍不一致。
我们系统检索了截至2019年10月的PubMed、Embase、Cochrane图书馆和ClinicalTrials.gov的记录,并对文章进行了初步和全文筛选。我们使用NOS量表评估纳入研究的质量,仅纳入中高质量研究。使用Review Manager 5.3和Stata15进行荟萃分析。
荟萃分析共纳入8项研究,涉及1676例患者。结果显示,对于采用二野和三野淋巴结清扫术的食管鳞状细胞癌,虽然三野淋巴结清扫术导致获取的淋巴结数量更多,但在阳性淋巴结数量和总生存率方面两者无显著差异。三野淋巴结清扫术还导致术中失血量增加和吻合口瘘的发病率更高。在手术时间、喉返神经损伤、肺炎、乳糜胸、吻合口狭窄、肠梗阻、颈部淋巴结复发和医院死亡率方面未观察到显著差异。
根据我们的荟萃分析,推荐二野淋巴结清扫术作为食管鳞状细胞癌的首选手术治疗方法。然而,由于结果显示存在偏倚风险,应谨慎对待。